Foresite Capital Management III, LLC - CYMABAY THERAPEUTICS INC ownership

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 136 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.

Quarter-by-quarter ownership
Foresite Capital Management III, LLC ownership history of CYMABAY THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$5,746,000
+18.6%
1,641,8040.0%15.17%
-13.7%
Q2 2022$4,843,000
-5.2%
1,641,8040.0%17.57%
+12.9%
Q1 2022$5,106,000
-8.0%
1,641,8040.0%15.56%
+10.8%
Q4 2021$5,549,000
-7.4%
1,641,8040.0%14.05%
+69.0%
Q3 2021$5,993,000
-16.3%
1,641,8040.0%8.31%
+9.5%
Q2 2021$7,158,000
-4.0%
1,641,8040.0%7.59%
+15.9%
Q1 2021$7,454,000
-20.9%
1,641,8040.0%6.54%
-40.3%
Q4 2020$9,424,000
-20.7%
1,641,8040.0%10.95%
+23.8%
Q3 2020$11,887,000
+112.9%
1,641,804
+2.6%
8.85%
+78.3%
Q2 2020$5,584,000
+89.4%
1,599,958
+6.3%
4.96%
+200.4%
Q4 2019$2,949,000
-61.8%
1,504,710
-0.2%
1.65%
-43.9%
Q3 2019$7,721,000
-32.1%
1,508,091
-5.0%
2.95%
-20.9%
Q2 2019$11,364,000
-46.1%
1,587,1010.0%3.73%
-32.1%
Q1 2019$21,077,000
+68.8%
1,587,1010.0%5.49%
+33.7%
Q4 2018$12,490,000
-27.8%
1,587,101
+1.6%
4.10%
+7.4%
Q3 2018$17,307,000
-17.4%
1,562,0400.0%3.82%
-15.4%
Q2 2018$20,963,000
+3.3%
1,562,0400.0%4.51%
+2.1%
Q1 2018$20,291,000
+267.6%
1,562,040
+160.3%
4.42%
+185.5%
Q4 2017$5,520,000
+14.1%
600,0000.0%1.55%
+16.3%
Q3 2017$4,836,000600,0001.33%
Other shareholders
CYMABAY THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 1,641,804$11,887,0008.85%
Foresite Capital Management IV, LLC 1,787,094$12,939,0002.92%
Copernicus Capital Management, LLC 278,416$2,016,0001.92%
Sio Capital Management, LLC 1,159,236$8,393,0001.66%
ACUTA CAPITAL PARTNERS, LLC 765,000$5,539,0001.50%
Avoro Capital Advisors LLC 10,300,000$74,572,0001.06%
Boxer Capital, LLC 4,000,000$28,960,0001.00%
Vivo Capital, LLC 2,089,356$15,127,0000.87%
EAM Global Investors LLC 284,534$2,060,0000.76%
Versant Venture Management, LLC 543,753$3,937,0000.72%
View complete list of CYMABAY THERAPEUTICS INC shareholders